IRTC - アイリズム・テクノロジ―ズ (iRhythm Technologies Inc.) アイリズム・テクノロジ―ズ

 IRTCのチャート


 IRTCの企業情報

symbol IRTC
会社名 iRhythm Technologies Inc (アイリズム・テクノロジ―ズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 アイリズム・テクノロジーズ(iRhythm Technologies Inc.)は米国のデジタルヘルス会社である。同社はバイオセンサー技術、患者データ、分析及び医療専門知識を統合するソリューションの開発・商業化に従事する。同社は主力ソリューションとZIOサービスを提供する。そのZIOサービスはZIO XTパッチ、アルゴリズム及びZIOレポートを含む。同社のmyZIOは、患者がZIOパッチを身に着けている間に起こたまたは持続した症状を入力するための方法を患者に提供する。同社のZIOイベントカードは失神、動悸及び息と眩暈の息切れ等の一過性症状が発生する患者のために使用される。同社のZIO XTパッチは高い患者コンプライアンス及び高い診断率を促進する非侵襲性且つ耐水性心臓モニターである。同社のアルゴリズムは捕獲された心拍データの量を分析する。その分析レポートは患者の医師に提供される。同社のZIOレポートは高い診断率を生成し、患者管理を変更する。   アイリズム・テクノロジ―ズは米国の医療機器メ―カ―。ウエアラブル端末であるバイオセンサ―を利用し、心臓の不整脈をクラウド・ベ―スの分析で臨床的に診断する。デジタル・ヘルスケア事業を展開し、同社開発の「ZIO」パッチは14日間装着が可能で、鼓動をデ―タ分析する。本社はカリフォルニア州サンフランシスコ。   iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.
本社所在地 650 Townsend Street Suite 500 San Francisco CA 94103 USA
代表者氏名 Abhijit Y. Talwalkar Abhijit Y. Talwalkar
代表者役職名 Independent Chairman of the Board
電話番号 +1 415-632-5700
設立年月日 38961
市場名 NASDAQ National Market System
ipoyear 2016年
従業員数 575人
url www.iRhythmTech.com
nasdaq_url https://www.nasdaq.com/symbol/irtc
adr_tso
EBITDA EBITDA(百万ドル) -36.77800
終値(lastsale) 83.17
時価総額(marketcap) 1991812214.62
時価総額 時価総額(百万ドル) 1912.781
売上高 売上高(百万ドル) 119.25100
企業価値(EV) 企業価値(EV)(百万ドル) 1859.439
当期純利益 当期純利益(百万ドル) -40.99600
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Irhythm Technologies Inc revenues increased 46% to $66M. Net loss increased 99% to $23.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Selling general and administrative - B increase of 64% to $55.8M (expense) Research and development - Balancing val increase of 56% to $7.2M (expense).

 IRTCのテクニカル分析


 IRTCのニュース

   Wearable Cardiac Monitors Market Clinical Aspects, Review, Survey Reports 2021-2027 - Medtronic, Koninklijke Philips, Abbott, iRhythm Technologies, Hill-Rom  2021/09/01 05:17:12 OpenPR
The Wearable Cardiac Monitors Market report 2021-2027 presents an in-depth assessment of key trends, current scenarios, challenges, standardization, regulatory landscape, and deployment models. Historical and futuristic case studies, opportunities, future roadmap, value chain, Key player profiles, and strategies lead to
   iRhythm® Technologies to Present at the 19th Annual Morgan Stanley Global Healthcare Conference  2021/08/26 20:05:00 Intrado Digital Media
SAN FRANCISCO, Aug. 26, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming 19 th Annual Morgan Stanley Global Healthcare Conference.
   Vident Investment Advisory, LLC Buys Luminar Technologies Inc, iRhythm Technologies Inc, Apple ...  2021/08/16 18:38:07 GuruFocus
Related Stocks: IRTC , AAPL , ABBV , FB , CMCSA , VCRA , LAZR , DOV , STTK , IBRX , AMC , TIL , CTB , MIK , SRRK , PRSP , MOR , AGCO ,
   The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma  2021/08/12 12:09:26 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (NASDAQ: ADGI ) (IPOed Friday) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Cytek Biosciences, Inc. (NASDAQ: CTKB ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Eliem Therapeutics, Inc. (NASDAQ: ELYM ) (IPOed Monday) Erasca, Inc. (NASDAQ: ERAS ) (IPOed July 16) Fulcrum Therapeutics, Inc. (NASDAQ: FULC ) (reacted to positive analyst actions following a positive clinical readout) IN8bio, Inc. (NASDAQ: INAB ) Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD ) Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI ) (announced second-quarter results) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE ) Rani Therapeutics Holdings, Inc. (NASDAQ: RANI ) (IPOed July 30) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 11) Adicet Bio, Inc. (NASDAQ: ACET ) Akero Therapeutics, Inc. (NASDAQ: AKRO ) Allogene Therapeutics, Inc. (NASDAQ: ALLO ) Aptose Biosciences Inc.
   iRhythm Technologies, Inc. (IRTC) CEO Doug Devine on Q2 2021 Results - Earnings Call Transcript  2021/08/08 13:32:05 Seeking Alpha
   HealthTech Market Worth Observing Massive Growth: Omron, Bay Labs, Inc., BioCardia Inc., iRhythm Technologies  2021/07/16 11:18:21 OpenPR
The fundamental report on HealthTech Market business report gives total foundation analysis of the business which incorporates an evaluation of the parental market. HealthTech Market division examinations the use of the component concerning its applications, end client or regarding topography.
   The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs  2021/07/15 12:07:56 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) - U.K. antitrust regulators cleared its pending acquisition by AstraZeneca PLC (NASDAQ: AZN ) Bristol-Myers Squibb Company (NYSE: BMY ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Moderna, Inc. (NASDAQ: MRNA ) PLx Pharma Inc. (NASDAQ: PLXP ) Zoetis Inc. (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 14) 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT ) 89bio, Inc. (NASDAQ: ETNB ) AbCellera Biologics Inc. (NASDAQ: ABCL ) Achilles Therapeutics plc (NASDAQ: ACHL ) Adicet Bio, Inc. (NASDAQ: ACET ) Adverum Biotechnologies, Inc. (NASDAQ: ADVM ) Akero Therapeutics, Inc. (NASDAQ: AKRO ) Allena Pharmaceuticals, Inc. (NASDAQ: ALNA ) ( announced a registered direct offering) Allogene Therapeutics, Inc. (NASDAQ: ALLO ) AlloVir, Inc. (NASDAQ: ALVR ) Aptose Biosciences Inc. (NASDAQ: APTO ) Avenue Therapeutics, Inc.
   The Daily Biotech Pulse: ScPharma''s Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues  2021/07/14 11:48:12 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical Holding Company Ltd. . (NYSE: BHVN ) AngioDynamics, Inc. (NASDAQ: ANGO ) (reacted to its fiscal-year 2021 fourth-quarter results) Bicycle Therapeutics plc (NASDAQ: BCYC ) ( announced Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ) exercised option to use its tissue-targeted delivery of oligonucleotide therapeutics tech) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Forward Pharma A/S (NASDAQ: FWP ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) PLx Pharma Inc. (NASDAQ: PLXP ) (announced availability of FDA-approved liquid-filled aspirin capsules in Walmart Inc. (NYSE: WMT ) stores) Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX ) Unicycive Therapeutics, Inc. (NASDAQ: UNCY ) (IPOed Tuesday) Zoetis Inc. (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 13) AbCellera Biologics Inc. (NASDAQ: ABCL ) Achilles Therapeutics plc (NASDAQ: ACHL ) Adicet Bio, Inc.
   iRhythm® Technologies Comments on the Centers for Medicare and Medicaid Services 2022 Proposed Medicare Physician Fee Schedule  2021/07/14 10:00:00 Intrado Digital Media
SAN FRANCISCO, July 14, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today provided comment on the recently released Centers for Medicare and Medicaid Services (CMS) Calendar Year 2022 Medicare Physician Fee Schedule Proposed Rule (the Proposed Rule). The Proposed Rule was released on July 13, 2021, and includes proposed, updated payment policies, payment rates, and other provisions for services furnished under the Medicare Physician Fee Schedule (MPFS) on or after January 1, 2022. The Proposed Rule is followed by a public comment period which will culminate with CMS release of a Final Rule, which is expected to be announced by early November for implementation on January 1, 2022. The policies announced in the Proposed Rule are therefore subject to change.
   iRhythm Technologies Stock Is Believed To Be Possible Value Trap  2021/07/10 06:00:08 GuruFocus
Related Stocks: IRTC ,
   Robert W. Baird Stick to Their Hold Rating for Irhythm Technologies By Investing.com  2021/04/20 09:15:40 Investing.com
Robert W. Baird Stick to Their Hold Rating for Irhythm Technologies
   BTIG Stick to Their Buy Rating for Irhythm Technologies By Investing.com  2021/04/10 21:45:01 Investing.com
BTIG Stick to Their Buy Rating for Irhythm Technologies
   FILING DEADLINE-Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CLOV, IRTC and NTNX - Stocks News Feed  2021/03/17 02:50:00 Stocks News Feed
CEDARHURST, N.Y., March 16, 2021 (GLOBE NEWSWIRE) — The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. Nutanix, Inc. (NTNX) Class Period: March 1, 2018 and May 30, 2019Lead Plaintiff Motion Deadline: March 22, 2021SECURITIES FRAUD To learn more, visit https://kclasslaw.com/cases/securities/nasdaqgs-ntnx/ iRhythm Technologies (IRTC)… Read More »FILING DEADLINE–Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CLOV, IRTC and NTNX
   SHAREHOLDER ALERT: CLAIMSFILER REMINDS CLOV, IRTC, PEN INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits - Stocks News Feed  2021/03/13 03:50:00 Stocks News Feed
NEW ORLEANS, March 12, 2021 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: Penumbra, Inc. (PEN) Class Period: 8/3/2020 – 12/15/2020Lead Plaintiff Motion Deadline: March 16, 2021SECURITIES FRAUD To learn more, visit https://www.claimsfiler.com/cases/view-penumbra-inc-securities-litigation iRhythm Technologies (IRTC) Class Period: 8/4/2020 – 1/28/2021Lead Plaintiff… Read More »SHAREHOLDER ALERT: CLAIMSFILER REMINDS CLOV, IRTC, PEN INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
   IRTC EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Announces that a Securities Fraud Class Action Lawsuit was filed on Behalf of Investors of iRhythm Technologies, Inc.  2021/03/05 02:47:00 PR Newswire
RADNOR, Pa., March 4, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds that an investor securities fraud class action lawsuit has been filed against iRhythm Technologies, Inc. (NASDAQ: IRTC) ("iRhythm") on behalf of those who purchased or acquired iRhythm…

 関連キーワード  (先端医療機器_テクノロジ― 米国株 アイリズム・テクノロジ―ズ IRTC iRhythm Technologies Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)